LXEO
Lexeo Therapeutics, Inc. Common StockNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$401.25M
P/E Ratio
—
EPS
$-1.12
Beta
1.53
52W High
$10.99
52W Low
$2.51
50-Day MA
$5.87
200-Day MA
$7.15
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Lexeo Therapeutics, Inc. Common Stock
Lexeo Therapeutics, Inc. is a clinical stage genetic medicine company that focuses on hereditary and acquired diseases. The company is headquartered in New York, New York.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | $-62.33M |
| EBITDA | $-97.18M |
| Operating Margin | 0.00% |
| Return on Equity | -54.80% |
| Return on Assets | -32.50% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $3.13 |
| Price-to-Book | 1.73 |
| Price-to-Sales (TTM) | 478.26 |
| EV/Revenue | 416.34 |
| EV/EBITDA | -6.02 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $78.52M |
| Float | $47.53M |
| % Insiders | 0.55% |
| % Institutions | 115.44% |
Historical Volatility
HV 10-Day
107.49%
HV 20-Day
83.63%
HV 30-Day
78.49%
HV 60-Day
73.65%
HV Rank
57.9%
Volatility is currently expanding
Analyst Ratings
Consensus ($20.60 target)
2
Strong Buy9
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026